Invesco S&P World Health Care ESG UCITS ETF (ETR:WH2E)
Germany · Delayed Price · Currency is EUR 6.12
+0.09 (1.48%)
Last updated: Sep 22, 2026, 5:30 PM CET
ETR:WH2E Holdings Information
ETR:WH2E is an equity ETF with a total of 81 individual holdings. The top holdings are Eli Lilly and Company stock at 16.02%, AbbVie at 11.78%, Merck & Co. at 7.30%, AstraZeneca at 4.69%, and Gilead Sciences at 4.56%.
Total Holdings
81
Top 10 Percentage
63.92%
Asset Class
Equity
ETF Category
Health Care
Assets
10.79M
PE Ratio
24.29
Breakdown by Asset Class
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 16.02% |
| 2 | ABBV | AbbVie Inc. | 11.78% |
| 3 | MRK | Merck & Co., Inc. | 7.30% |
| 4 | LON: AZN | AstraZeneca PLC | 4.69% |
| 5 | GILD | Gilead Sciences, Inc. | 4.56% |
| 6 | SWX: ROP | Roche Holding AG | 4.33% |
| 7 | SWX: NOVN | Novartis AG | 4.24% |
| 8 | AMGN | Amgen Inc. | 3.69% |
| 9 | ABT | Abbott Laboratories | 3.68% |
| 10 | TMO | Thermo Fisher Scientific Inc. | 3.64% |
| 11 | DHR | Danaher Corporation | 2.46% |
| 12 | BMY | Bristol-Myers Squibb Company | 2.44% |
| 13 | MDT | Medtronic plc | 2.31% |
| 14 | PFE | Pfizer Inc. | 2.23% |
| 15 | UNH | UnitedHealth Group Incorporated | 1.78% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.63% |
| 17 | SYK | Stryker Corporation | 1.28% |
| 18 | EW | Edwards Lifesciences Corporation | 1.19% |
| 19 | BSX | Boston Scientific Corporation | 1.11% |
| 20 | EPA: SAN | Sanofi | 1.06% |
| 21 | LON: GSK | GSK plc | 0.95% |
| 22 | ASX: CSL | CSL Limited | 0.90% |
| 23 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 0.86% |
| 24 | A | Agilent Technologies, Inc. | 0.79% |
| 25 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 0.78% |
As of Sep 18, 2026